
Siddharth Singhal
04/09/26
Every certificate and licence behind the Vibcare range, from both companies, with the numbers you can check yourself.
Reviewed by Siddharth Singhal, Managing Director, Vibcare Pharma · September 2026
"WHO-GMP certified" is the most repeated and least verified phrase in the PCD pharma business. This page lists the certificates and licences behind the Vibcare range exactly as they were issued – certificate numbers, the government office or certifying body that issued them, the dates, what they cover and until when – so that a distributor, a doctor or a hospital purchase team can check them rather than take our word for it.
Vibcare Pharma Pvt Ltd is the company whose name is on the franchise agreement, the invoice and the GST. These are its own documents: the two wholesale drug licences it trades under, the retention acknowledgement that keeps them current, its ISO 9001:2015 certificate for trading and marketing, and its GST registration.





Signatures masked. Every number, office, date and stamp is as issued.
Vibcare Healthcare Pvt Ltd is the group’s own manufacturing company at Dabkori, Panchkula, with the same directors as Vibcare Pharma. The tablets, capsules, oral liquids and external preparations in the Vibcare range are made there. These are the plant’s certificates.



Scans of the issued certificates. Click WhatsApp above for the full-size PDFs.
| Certificate | Detail |
|---|---|
| Vibcare Pharma Pvt Ltd — marketing | |
| Wholesale drug licence – Form 20-B | No. HR-11-1653-OW/H · granted 12 July 2017 (ref. FDA/ZONE/2404) by the Senior Drugs Control Officer-cum-Licensing Authority, Ambala Zone · covers drugs other than those specified in Schedules C, C(1) and X · premises: Plot No. 4, FF, Sector 22, HSIIDC IT Park, Panchkula · retained to 11 July 2027 |
| Wholesale drug licence – Form 21-B | No. HR-11-1653-W/H · granted 12 July 2017 · same licensing authority and premises · covers drugs specified in Schedules C and C(1), excluding Schedule X · retained to 11 July 2027 |
| Licence retention | Retention fee of Rs 3,000 deposited on challan no. 0092125935 dated 4 July 2022 for the period 12 July 2022 to 11 July 2027 · acknowledged on the same letter by the Licensing Authority, Ambala Zone on 6 and 7 July 2022 |
| Competent person | Sh. Siddharth Singhal, named on both licences as the competent person supervising sale |
| ISO 9001:2015 – Vibcare Pharma | Certificate No. US-VBPT-25-25255391 · issued 25 March 2025 by U.S. Certification (IAB-accredited) · scope: trading and marketing of pharmaceutical products · surveillance audits due 24 March 2026 and 24 March 2027; re-certification due 24 March 2028 · verify at uscertifications.uk |
| GST registration | GSTIN 06AAECV4940M1ZZ · Form GST REG-06, regular registration · liable from 1 July 2017, certificate issued 28 July 2018 · no expiry date · verifiable in the Search Taxpayer tool on gst.gov.in |
| Registered office | Vibcare Pharma Pvt Ltd, Plot No. 4, HSIIDC IT Park, Sector 22, Panchkula 134109, Haryana – registered 2014, trading since 2015 |
| Vibcare Healthcare Pvt Ltd — manufacturing | |
| WHO-GMP Site Certificate | No. 1/182-1Drug-I-2024 · issued 24 October 2024 by the State Drugs Controller-cum-Licensing Authority, Food and Drugs Administration, Haryana, Panchkula, after joint inspections on 30 September, 1 October and 21 October 2024 · valid three years from issue · scope: tablets (non beta-lactam), capsules (non beta-lactam), external preparations (non beta-lactam), oral liquids – production, packing and quality control |
| GMP Certificate (Revised Schedule M) | Memo No. 1/182-1Drug-1-2024 · dated 14 November 2024 · Office of the State Drugs Controller, FDA Haryana · certifies compliance with Good Manufacturing Practices under Revised Schedule M of the Drugs Rules, 1945 · valid three years from issue |
| Drug manufacturing licences | Form 25: MLF252023HR000004 · Form 28: MLF282023HR000005 · under the Drugs and Cosmetics Act, 1940 · valid up to 7 May 2028 · for tablets, capsules, oral liquids and external preparations (non beta-lactam) |
| ISO 9001:2015 – Vibcare Healthcare | Certificate No. US-VTRM-25-25255390 · issued 25 March 2025 by U.S. Certification (IAB-accredited) · scope: medicaments put up in measured doses or in forms or packings for retail sale · annual surveillance audits; re-certification due 24 March 2028 · verify at uscertifications.uk |
| Certified site | Vibcare Healthcare Pvt Ltd, Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana – the group’s own manufacturing company; 100,000 sq ft facility |
| Third-party manufactured ranges | Injectables, ophthalmics and the NURALZ ayurvedic range are made at partner WHO-GMP units; each batch ships with its own certificate of analysis and the manufacturer’s name on the pack |
| Documents on request | PDF copies of every certificate and licence on this page, the certificate of analysis for any batch, and the product permission list |
Three different documents get called "GMP" in conversation. They are not the same thing, and a distributor who knows the difference asks better questions of every company he talks to.
Issued by the State Drugs Controller after an inspection under the WHO-GMP certification scheme. It certifies that the specific site, for the specific dosage forms listed in its Table 1, follows Good Manufacturing Practices as laid down by the WHO. It is the document hospitals, institutional tenders and export buyers ask for. Ours is issued to the plant at Dabkori, Panchkula, for tablets, capsules, external preparations and oral liquids, and it is valid for three years from 24 October 2024. Note what it does not cover: injectables. Ours are made at a separate WHO-GMP certified unit, and we say so on every page.
Schedule M is the Indian GMP standard under the Drugs Rules, 1945. The revised Schedule M notified in December 2023 raised the bar to align with WHO standards, and from 2025 every manufacturer has to comply with it. A GMP certificate under Revised Schedule M means the state licensing authority inspected the plant against the new standard and found it compliant. Companies still operating on old Schedule M compliance will have to upgrade or stop; a distributor should ask which version a supplier's certificate refers to.
These are the legal permission to manufacture. Form 25 covers non-Schedule C drugs (tablets, capsules, most oral liquids and external preparations); Form 28 covers Schedule C and C1 drugs. A certificate is a quality statement; a licence is the legal right to make the product at all. Both of ours are valid until 7 May 2028. Every product we supply is manufactured under one of these licences or, for third-party ranges, under the partner unit's licence named on the pack.
A quality-management-system standard, not a pharmaceutical standard. It certifies that the company has documented processes, records deviations, audits itself and corrects what it finds. It is issued by a private certifying body, not a government office, and it stays valid only if the annual surveillance audit is passed. It says nothing about GMP by itself; it matters in combination with the FDA-issued certificates above.
| # | What to check | Vibcare's answer |
|---|---|---|
| 1 | Does the company you sign with hold its own drug licence? | Yes. Vibcare Pharma Pvt Ltd holds Form 20-B (HR-11-1653-OW/H) and Form 21-B (HR-11-1653-W/H), Licensing Authority, Ambala Zone, retained to 11 July 2027. |
| 2 | Is its GST registration active and in the same name? | Yes. GSTIN 06AAECV4940M1ZZ, Vibcare Pharma Private Limited, regular registration, no expiry date. |
| 3 | Is there a WHO-GMP site certificate, with a number and issuing office? | Yes. No. 1/182-1Drug-I-2024, State Drugs Controller, FDA Haryana, 24 October 2024. |
| 4 | Is the GMP certificate under Revised Schedule M? | Yes. Dated 14 November 2024, FDA Haryana. |
| 5 | Are the manufacturing licences current? | Yes. Form 25 and Form 28, valid to 7 May 2028. |
| 6 | Do the products you will sell fall inside the certified dosage forms? | Tablets, capsules, oral liquids and external preparations – yes. Injectables, ophthalmics and ayurvedic – third-party WHO-GMP units, stated on their pages. |
| 7 | Is ISO 9001:2015 current, with a verifiable number? | Yes. US-VBPT-25-25255391 for Vibcare Pharma and US-VTRM-25-25255390 for Vibcare Healthcare, both issued 25 March 2025 and verifiable online. |
| 8 | Will the company send the PDFs and a batch COA before you order? | Yes. Same day, on WhatsApp. |
Send your district and the range you want on WhatsApp. You get the certificate PDFs, licence numbers, product list with net rates and available districts – no franchise fee, no deposit.
The plant that manufactures the Vibcare range – Vibcare Healthcare Pvt Ltd, Dabkori, Panchkula – holds a WHO-GMP site certificate, No. 1/182-1Drug-I-2024, issued by the State Drugs Controller, FDA Haryana on 24 October 2024 after inspection, covering tablets, capsules, external preparations and oral liquids. Vibcare Pharma Pvt Ltd is the marketing company of the same group. The certificate PDF is sent on request.
Yes. Vibcare Pharma Pvt Ltd holds two wholesale drug licences issued by the Licensing Authority, Ambala Zone – Form 20-B No. HR-11-1653-OW/H for drugs outside Schedules C, C(1) and X, and Form 21-B No. HR-11-1653-W/H for Schedule C and C(1) drugs – both for the premises at Plot No. 4, Sector 22, HSIIDC IT Park, Panchkula. They were granted on 12 July 2017 and retained on challan no. 0092125935 for the period to 11 July 2027. The company also holds GST registration 06AAECV4940M1ZZ and ISO 9001:2015 certificate US-VBPT-25-25255391. Scans of all of them are on this page.
Schedule M is the Indian GMP standard under the Drugs Rules, 1945; the revised Schedule M notified in December 2023 aligns it with WHO standards. The WHO-GMP site certificate is issued under the WHO-GMP certification scheme after a separate inspection and lists the dosage forms it covers. Vibcare Healthcare holds both: the WHO-GMP site certificate of October 2024 and the GMP certificate under Revised Schedule M of November 2024.
Injectables, ophthalmic preparations and the NURALZ ayurvedic range are manufactured at third-party WHO-GMP certified units, because the plant's licences and WHO-GMP certificate cover tablets, capsules, oral liquids and external preparations. The manufacturer's name and licence appear on those packs, and each batch ships with its certificate of analysis.
Haan. WhatsApp par district aur range batayein; usi din WHO-GMP, GMP aur ISO certificate ki PDF, dono manufacturing licence number aur product list net rates ke saath milti hai. Kisi bhi batch ka certificate of analysis bhi order se pehle maang sakte hain.
Yes. Licence MLF252023HR000004 (Form 25) and MLF282023HR000005 (Form 28), issued under the Drugs and Cosmetics Act, 1940 by FDA Haryana, are valid up to 7 May 2028 for tablets, capsules, oral liquids and external preparations (non beta-lactam).
No. ISO 9001:2015 certifies a quality management system – documented processes, internal audits, corrective action – and is issued by a private certifying body, in our case U.S. Certification, certificate US-VTRM-25-25255390 dated 25 March 2025. It complements the FDA-issued WHO-GMP and GMP certificates; it does not replace them.
Send your district and the range you want. You will receive the certificate PDFs, licence numbers, product list and net rates on WhatsApp.
Vibcare Pharma Pvt Ltd, Plot 4, HSIIDC IT Park, Sector 22, Panchkula, Haryana.
Related pages
Copy Link